Blaze Therapeutics, a Veteran Owned Company
Updated: Nov 13, 2019
Because of our American military Veterans, we are afforded the freedoms that make America great. Each U.S. military Veteran has taken the Oath of Enlistment and has pledged to put their lives on the line for our country and for our rights. Unfortunately, Veterans are subject to progressive illnesses directly related to their military service such as chronic pain and posttraumatic stress disorder (PTSD). Of the approximately 20 million Veterans currently in the United States today, 50% are receiving care at Veterans Health Administration (VHA) facilities across the country for chronic pain. An estimated 15 to 35% of those Veterans living with chronic pain, also have PTSD. After adjusting for differences in age and sex, risk for suicide is 22% higher among Veterans when compared to U.S. non-Veteran adults.
Being a Veteran owned company, Blaze Therapeutics recognizes the importance of taking care of our Veterans and service members. Under the leadership of Vincent Crowley, Blaze Therapeutics regularly tours the United States educating healthcare professionals at VHA facilities about the effects of CBD derived from hemp and teaming up with advocates to provide guidance and assistance to the Veteran community regarding navigating the CBD market and identifying high quality nutraceutical products.
Vincent Crowley, Co-Founder and Senior Vice President of Blaze Therapeutics
Mr. Crowley is a veteran of the United States military and a passionate advocate for the veteran community and military at large. Mr. Crowley enlisted into the Army on February 21, 2012. In May of 2015, Mr. Crowley was injured during service, which ultimately lead him down a difficult path of chronic pain, depression and insomnia. Mr. Crowley refused to treat his physical pain with surgery, injections and the consumption of opioid medications in an attempt to avoid developing any physical addictions. Two years after his initial injury, Mr. Crowley was medically retired May of 2017.
During his years of service, Mr. Crowley discovered a heightened awareness for his core values, and beliefs (i.e loyalty, duty, respect, selfless service, honor, integrity, and personal courage). Incorporating these core values into his daily life and his passion to help other service members navigate life post military service and transition back into the civilian sector, spurred an interest to earn a degree in Psychology and Mental Health. As a student of the University of Maryland University College, Mr. Crowley makes himself available to veterans seeking guidance through social media platforms and in person meetings. Through Blaze Therapeutics, Mr. Crowley is leading the effort to introduce the military community to Responsibly Distributed CBD nutraceuticals as alternative options to addressing their health concerns.
Why CBD?
Cannabidiol (CBD) derived from hemp has been found to help PTSD patients manage their symptoms, as well as help patients suffering from chronic pain consume less opioids to manage their daily pain levels. Given the substantial amount of growing evidence of the therapeutic effects of hemp-derived nutraceuticals, Blaze Therapeutics is determined to serve and offer guidance to communities in need of therapeutic solutions, like the Veteran community and the rare disease community. If you are interested in learning more about Blaze Therapeutics, do not hesitate to contact us at info@blazetherapeutics.com or give us a call at 833-422-5293.
References:
1. Chronic pain: symptoms, diagnosis, & treatment. NIH MedlinePlus. 2011 6(1):5-6. Available at https://medlineplus.gov/magazine/issues/spring11/articles/spring11pg5-6.html. Accessed October 20, 2017.
2. Veteran Population Projections 2017-2037. US Department of Veterans Affairs. Available at www.va.gov/vetdata/docs/Demographics/New_Vetpop_Model/Vetpop_Infographic_Final31.pdf. Accessed October 18, 2017.
3. Opioid Prescribing to High-Risk Veterans Receiving VA Purchased Care. Department of Veterans Affairs Office of Inspector General. Available at www.va.gov/oig/pubs/VAOIG-17-01846-316.pdf. Accessed February 6, 2018.
4. DoD Worldwide TBI Numbers. Defense and Veterans Brain Injury Center. Available at http://dvbic.dcoe.mil/dod-worldwide-numbers-tbi. Accessed November 8, 2017.
5. Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA. 2008;300(6):711-719.
6. Potter, C.M., Vujanovic, A.A., Marshall-Verenz, E.C., Bernstein, A., and Bonn-Miller, M.O. (2011, April). Posttraumatic stress and Cannabis use coping motives: the mediating role of distress tolerance. Journal of Anxiety Disorders, 25(3), 437-43.
7. Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States. Lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177(5):611–612. doi:10.1001/jamainternmed.2017.0147
8. Chronic Pain and PTSD: A Guide for Patients. National Center for PTSD. US Department of Veterans Affairs. Available at https://www.ptsd.va.gov/public/problems/pain-ptsd-guide-patients.asp. Accessed October 30, 2017.
9. Understanding PTSD and PTSD Treatment. National Center for PTSD. US Department of Veterans Affairs. 2017. Available at https://www.ptsd.va.gov/public/understanding_ptsd/booklet.pdf. Accessed October 30, 2017.
10. VA/DOD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder. US Department of Veterans Affairs. 2017. Available at www.healthquality.va.gov/guidelines/MH/ptsd/VADoDPTSDCPGPocketCardFinal.pdf. Accessed November 8, 2011.
11. Prolonged Exposure (PE). Clinical Practice Guidelines for the Treatment of Post-tramatic Stress Disorder. American Psychological Association. Available at www.apa.org/ptsd-guideline/treatments/prolonged-exposure.aspx. Accessed February 6, 2018.
12. Severe Pain in Veterans: The Effect of Age and Sex, and Comparisons With the General Population. [Abstract]. (2017). Pubmed,(18), 3rd ser., 247-254. doi:10.1016/j.jpain.2016.10.021
13. Veterans statistics: PTSD, Depression, TBI, Suicide. (2015, September 15). Retrieved August 25, 2018, from http://www.veteransandptsd.com/PTSD-statistics.html
14. Walsh, Z., Gonzalez, R., Crosby, K., S Thiessmen, M., Carroll, C., and Bonn-Miller, M.O. (2016, October 12). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15-29.